Digital health interventions enhance care efficacy in dermatology
The world of dermatology is set to experience transformative improvements in patient care, thanks to the integration of Digital Health Interventions (DHIs). This finding is a result of a systematic review and mapping study undertaken recently by researchers.
DHIs, as catalogued by the World Health Organization (WHO) in 2018, span a broad range of digital tools encompassing telemedicine, mobile health apps, wearable tech, and advanced artificial intelligence (AI) algorithms. One of the standout benefits of telemedicine as a DHI, as highlighted by the research of Reinders et al, includes notable merits like significantly shortened waiting periods, heightened levels of patient satisfaction, and diagnostic precision on par with traditional methods.
Reinders and team elucidated that DHIs bring about enhancements through a plethora of channels. These channels range from harnessing data analytics to refine decision-making in both diagnosis and treatment, fostering effective communication among stakeholders in patient care, and bolstering patient self-management in chronic conditions. Additionally, DHIs also play a pivotal role in the proactive promotion of health-conscious behaviours.
In their quest to dive deeper into DHIs and their application in dermatology, the team undertook a comprehensive review of the MEDLINE (PubMed) database in August 2022. Their search parameters encompassed a wide range of terms, including but not limited to “digital health,” “eHealth,” “mHealth,” and specific dermatological conditions. To ensure contemporary relevance, studies before 2010 were not considered for the analysis due to the swift pace of technological progression post that period.
In terms of selection criteria, the team opted for studies that embraced quantitative methods. Additionally, studies that explored AI algorithms’ prowess were required to benchmark these algorithms against the conventional, human-driven standard of care, either in a practical real-world scenario or within a commercially available software framework.
To ensure rigorous evaluation, a consortium of 2 to 3 experts, depending on the study’s complexity, assessed the relevance and fit of all collated studies. This assessment encapsulated a diverse range of attributes, from the study’s design, origin, and participant count to its specific focus on DHI as per WHO’s classifications.
After meticulous scrutiny, a total of 403 studies were integrated into the final review. A remarkable insight was the discernible surge in DHI-centric research in recent times, predominantly in the domains of store-and-forward (S&F) teledermatology and AI-driven image analytics. A significant emphasis was noted on skin cancer identification, with 148 studies specifically focusing on this area. Other dermatological conditions, including acne, psoriasis, and wounds, also featured in DHI studies, albeit to a lesser extent.
In their concluding remarks, Reinders and team observed, “The momentum in DHI-focused studies is palpable, with an accelerating trend over the recent years. This acceleration is primarily driven by advancements in S&F teledermatology and AI applications, with a pronounced focus on skin cancer diagnosis and its intersection with healthcare providers. The gamut of DHIs evaluated across diverse user groups and varied use-cases underscores the immense potential DHIs hold for dermatology’s future. Yet, to harness the full spectrum of DHIs’ potential, there’s an evident need for deeper research, especially in areas like ongoing management of chronic skin conditions and efficient patient triage.”
